7 enterprises won the bid for designated production of basic drugs in 2014

Source: cerberyl 2014-12-30 December 29, the drug management center issued the announcement on the results of bidding evaluation of designated manufacturers of essential drugs in 2014, and 7 pharmaceutical enterprises became designated manufacturers of 4 basic drug varieties As the bidding price has fallen again and again, many low-cost medicine life-saving drugs are in short supply According to media reports, the price of each bottle of methimazole tablets for the treatment of hyperthyroidism is less than 2 yuan, which is lower than the production cost of the enterprise Since this year, this drug has been in short supply in many places In Beijing, a five bottle policy has been adopted On July 31, the Ministry of industry and information technology, the health and Family Planning Commission and the State Administration of food and Drug Administration issued the notice on entrusting to carry out the bidding work of designated manufacturers of essential drugs According to the bidding plan, the first batch of bidding was ergonoxine injection, deacetylhairoside injection, dapsone tablet, procainamide injection, lobeline injection, dobutamine injection and other six varieties In principle, there are two winning enterprises for each variety Only one enterprise with production conditions can choose one But judging from the result of winning the bid, the methimazole tablets that were no longer listed in the bidding catalogue were included in the fixed-point production catalogue Previously, the only manufacturer reported by the media was selected as the fixed-point unit However, only three bidding varieties have been announced this time, and the bidding results of ergometrine injection, dapsone tablet, procaine amine injection and other three varieties have yet to be announced The following is the list of bid winning enterprises published by the health and Family Planning Commission: the health and Family Planning Commission also said that if there is any objection to this, it can be put forward to the drug management center of the national health and Family Planning Commission in written form with the official seal of the unit within 20 working days from the date of this announcement.